Vimseltinib Alternatives Compared
Vimseltinib | Turalio (pexidartinib) | Pexidartinib |
|
---|
Vimseltinib | Turalio (pexidartinib) | Pexidartinib |
|
---|---|---|---|
Prescription only
Prescribed for Tenosynovial Giant Cell Tumor. Vimseltinib may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Tenosynovial Giant Cell Tumor. Turalio may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Tenosynovial Giant Cell Tumor. Pexidartinib may also be used for purposes not listed in this medication guide. |
Related suggestions Tenosynovial Giant Cell Tumor
|
More about Vimseltinib | More about Turalio (pexidartinib) | More about Pexidartinib | |
Ratings & Reviews | |||
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
Pexidartinib has an average rating of 8.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
|
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||
View all Vimseltinib side effects |
View all Turalio side effects |
View all Pexidartinib side effects |
|
Drug Class | |||
Generic Availability | |||
N/A |
N/A |
||
Pricing and Coupons * Prices are without insurance | |||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
Dosage Forms | |||
N/A |
|
N/A |
|
Brand Names | |||
Romvimza |
N/A |
Turalio | |
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||
144 hours |
26.6 hours |
26.6 hours |
|
CSA Schedule 1 View glossary of CSA terms | |||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
Pregnancy Category | |||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
|
Drug Interactions | |||
A total of 135 drugs are known to interact with Vimseltinib:
|
A total of 647 drugs are known to interact with Turalio:
|
A total of 647 drugs are known to interact with Pexidartinib:
|
|
Alcohol/Food/Lifestyle Interactions | |||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||
Disease Interactions | |||
First Approval Date | |||
February 14, 2025 |
August 02, 2019 |
August 02, 2019 |
|
WADA Class View classifications | |||
N/A |
N/A |
N/A |
|
More Information | |||
Patient Resources | |||
Professional Resources | |||
Related Treatment Guide | |||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Romvimza
Romvimza is used to treat symptomatic tenosynovial giant cell tumor (TGCT) in adults when surgery ...
Turalio
Turalio (pexidartinib) is a kinase inhibitor for the treatment of tenosynovial giant cell tumor ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Accutane
Accutane (isotretinoin) is a form of vitamin A and is used to treat severe nodular acne. Includes ...
Adstiladrin
Adstiladrin (nadofaragene firadenovec-vncg) is a gene therapy used to treat high-risk Bacillus ...
Amnesteem
Amnesteem is used for acne, acute nonlymphocytic leukemia, granuloma annulare, rosacea
Amtagvi
Amtagvi (lifileucel) is a type of medicine called “tumor-derived autologous T cell immunotherapy” th ...
Anktiva
Anktiva (N-803) is used to treat specific types of bladder cancer. It is FDA-approved to be used ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.